KORU Medical Systems, Inc. (KRMD) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated August 7, 2024, announces the financial results for KORU Medical Systems, Inc. for the fiscal quarter ended June 30, 2024. The company, incorporated in Delaware, operates in the medical technology sector and trades on The Nasdaq Stock Market under the symbol KRMD.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification of the results and a reference to the attached press release (Exhibit 99.1) for detailed figures.
The company highlights the use of the following non-GAAP financial measures to supplement GAAP results:
- Adjusted EBITDA: Defined as net income/loss before interest, taxes, depreciation, amortization, reorganization charges, deferred tax asset allowances, and stock-based compensation.
- Adjusted EPS: Diluted earnings per share adjusted for income tax, depreciation, amortization, and stock-based compensation to reflect ordinary operations.
Material Changes and Comparisons
The filing text does not contain specific data regarding material changes versus the prior comparable period. Investors are directed to the press release and conference call for a comparison of ongoing results of operations.
Guidance, Outlook, and Management Commentary
Management intends to hold a conference call on August 7, 2024, at 4:30 pm Eastern Time to discuss the results. The company emphasizes that non-GAAP measures are used internally for planning, forecasting, and evaluating performance trends. A reconciliation of GAAP to non-GAAP results is provided in Exhibit 99.1.
Risks and Contingencies: The filing cautions that non-GAAP measures may differ from similar measures used by other companies and should not be considered replacements for GAAP financial measures. The information in Item 2.02 is furnished and not deemed "filed" under Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the quarter ended June 30, 2024.
- Examine the reconciliation table in the press release to understand the adjustments made to derive Adjusted EBITDA and Adjusted EPS.
- Verify the company's liquidity position and debt levels in the full financial statements referenced in the press release.
- Listen to the conference call transcript for management's commentary on year-over-year trends and future outlook.